JACC. Asia
Sex Differences in Antiarrhythmic Effects of Empagliflozin: The EMPA-ICD Trial Subanalysis.
Miyo Nakano, Yusuke Kondo, Shinya Fujiki, Yuki Shiko, Yohei Kawasaki, Yoshihisa Nakagawa, Kazuyoshi Takahashi, Masaaki Okabe, Kengo Kusano, Shingen Owada, Kenichi Tsujita, Yoshiaki Kubota, Hirofumi Tomita, Toshihisa Anzai, Kenichi Iijima
Published: 202610.1016/j.jacasi.2025.11.017
Abstract
BACKGROUND: The EMPA-ICD (Empagliflozin in Patients with Type 2 Diabetes Treated with an Implantable Cardioverter-Defibrillator; jRCTs031180120) trial is a prospective, multicenter, randomized, double-blind, placebo-controlled study evaluating the ef…
Preview only. Read the full abstract at the source